A clinical evaluation of the effect of maintaining haemoglobin levels with weekly EPREX®/ERYPO® (Epoetin alfa) in subjects with lymphoid malignancies (Hodgkin’s Disease, Non-Hodgkin’s Lymphoma, Chronic Lymphocytic Leukemia and Multiple Myeloma) undergoing chemotherapy Posted on May 21, 2019 by tsuperadmin -
NCT00211120 – Correction of Hemoglobin and Outcomes In Renal Insufficiency (CHOIR) Posted on April 25, 2019 by tsuperadmin -
NCT00211146 – An Open-Label, Randomized, Parallel-Group Study to Confirm the Safety and Efficacy of Epoetin Alfa (PROCRIT) Administered Perioperatively vs. the Standard of Care in Blood Conservation in Subjects Undergoing Major Elective Spinal Surgery Posted on January 23, 2018 by tsuperadmin -
NCT01394991 – A Randomized, Open-Label, Multicenter Study Evaluating Thrombovascular Events in Subjects With Cancer Receiving Chemotherapy and Administered Epoetin Alfa Once or Three Times a Week for the Treatment of Anemia Posted on January 23, 2018 by tsuperadmin -
NCT00266617 – The Effect of Subcutaneous r-HuEPO in Patients With Chronic Anemia Secondary to Chemotherapy Posted on November 10, 2017 by tsuperadmin -
NCT00269997 – The Effect of Subcutaneous r-HuEPO in Patients With Chronic Anemia Secondary to Cisplatin Chemotherapy Posted on November 10, 2017 by tsuperadmin -
NCT00210626 – A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Effect of Recombinant Human Erythropoietin (Epoetin Alfa (PROCRIT®)) on Functional Outcomes in Anemic, Critically Ill, Trauma Subjects Posted on January 12, 2017 by tsuperadmin -
Efficacy in the rHuEPO (Epoetin Alfa) in the Critically Ill Patient: A Randomized, Double Blind, Placebo-Controlled trial Posted on October 29, 2015 by tsuperadmin -
NCT00091910 – A Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficacy and Safety of Epoetin Alfa in Critically Ill Subjects Posted on October 20, 2015 by tsuperadmin -
NCT00270283 – A Double-Blind, Placebo-Controlled Study With Open-Label Follow-up to Determine the Safety and Efficacy of Subcutaneous Doses of r-HuEPO in AIDS Patients With Anemia Induced by Their Disease and AZT Therapy Posted on October 20, 2015 by tsuperadmin -